These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1486 related items for PubMed ID: 23623721
1. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Montemezzi S, Macaskill P. Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721 [Abstract] [Full Text] [Related]
2. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Bernardi D, Macaskill P, Pellegrini M, Valentini M, Fantò C, Ostillio L, Tuttobene P, Luparia A, Houssami N. Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635 [Abstract] [Full Text] [Related]
4. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies. Houssami N, Macaskill P, Bernardi D, Caumo F, Pellegrini M, Brunelli S, Tuttobene P, Bricolo P, Fantò C, Valentini M, Ciatto S. Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887 [Abstract] [Full Text] [Related]
5. Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: Evidence from a population-based trial. Houssami N, Bernardi D, Pellegrini M, Valentini M, Fantò C, Ostillio L, Tuttobene P, Luparia A, Macaskill P. Cancer Epidemiol; 2017 Apr; 47():94-99. PubMed ID: 28192742 [Abstract] [Full Text] [Related]
7. Effect of integrating digital breast tomosynthesis (3D-mammography) with acquired or synthetic 2D-mammography on radiologists' true-positive and false-positive detection in a population screening trial: A descriptive study. Bernardi D, Li T, Pellegrini M, Macaskill P, Valentini M, Fantò C, Ostillio L, Houssami N. Eur J Radiol; 2018 Sep; 106():26-31. PubMed ID: 30150047 [Abstract] [Full Text] [Related]
9. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study. Zackrisson S, Lång K, Rosso A, Johnson K, Dustler M, Förnvik D, Förnvik H, Sartor H, Timberg P, Tingberg A, Andersson I. Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817 [Abstract] [Full Text] [Related]
10. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial. Houssami N, Bernardi D, Caumo F, Brunelli S, Fantò C, Valentini M, Romanucci G, Gentilini MA, Zorzi M, Macaskill P. Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943 [Abstract] [Full Text] [Related]
12. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Breast Cancer Res; 2012 Jan 09; 14(1):R10. PubMed ID: 22230363 [Abstract] [Full Text] [Related]
13. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. van Luijt PA, Fracheboud J, Heijnsdijk EA, den Heeten GJ, de Koning HJ, National Evaluation Team for Breast Cancer Screening in Netherlands Study Group (NETB). Eur J Cancer; 2013 Nov 09; 49(16):3517-25. PubMed ID: 23871248 [Abstract] [Full Text] [Related]
14. Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice. Greenberg JS, Javitt MC, Katzen J, Michael S, Holland AE. AJR Am J Roentgenol; 2014 Sep 09; 203(3):687-93. PubMed ID: 24918774 [Abstract] [Full Text] [Related]
15. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2). Tagliafico AS, Mariscotti G, Valdora F, Durando M, Nori J, La Forgia D, Rosenberg I, Caumo F, Gandolfo N, Sormani MP, Signori A, Calabrese M, Houssami N. Eur J Cancer; 2018 Nov 09; 104():39-46. PubMed ID: 30316869 [Abstract] [Full Text] [Related]
16. Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2). Bernardi D, Houssami N. Breast; 2017 Apr 09; 32():98-101. PubMed ID: 28107735 [Abstract] [Full Text] [Related]
18. Comparison of full-field digital mammography and digital breast tomosynthesis in ultrasonography-detected breast cancers. Nam KJ, Han BK, Ko ES, Choi JS, Ko EY, Jeong DW, Choo KS. Breast; 2015 Oct 09; 24(5):649-55. PubMed ID: 26292782 [Abstract] [Full Text] [Related]
19. Radiologists' interpretive efficiency and variability in true- and false-positive detection when screen-reading with tomosynthesis (3D-mammography) relative to standard mammography in population screening. Svahn TM, Macaskill P, Houssami N. Breast; 2015 Dec 09; 24(6):687-93. PubMed ID: 26433751 [Abstract] [Full Text] [Related]
20. Digital breast tomosynthesis (3D-mammography) screening: A pictorial review of screen-detected cancers and false recalls attributed to tomosynthesis in prospective screening trials. Houssami N, Lång K, Bernardi D, Tagliafico A, Zackrisson S, Skaane P. Breast; 2016 Apr 09; 26():119-34. PubMed ID: 27017251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]